Position in RLAY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,847
+$6,619 QoQ
Shares Held
366
+1491.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#239
of 256 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $22,018,760 across 201 Biotechnology names. RLAY ranks #56 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VIR |
Vir Biotechnology, Inc.
|
608,234 | $6,197,904 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
341,711 | $2,991,679 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,510 | $2,240,252 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
60,620 | $2,080,478 | |
| 5 | NAUT |
Nautilus Biotechnology, Inc.
|
892,787 | $1,669,511 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
13,058 | $718,190 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,813 | $714,098 | |
| 8 | SANA |
Sana Biotechnology, Inc.
|
170,739 | $595,879 |
All Filings in RLAY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,847 | 366 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $228 | 23 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $287 | 34 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,581 | 303 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $44 | 13 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||